Search Results - "Polverino, E."

Refine Results
  1. 1

    Cystic fibrosis: desensitization in delayed hypersensitivity reactions to elexacaftor/tezacaftor/ivacaftor by Gómez-Ganda, L, Galván-Blasco, P, Fernández-Polo, A, Cardona, V, García-Palop, B, Parramón-Teixidó, C J, Polverino, E, Álvarez-Fernández, A

    Published in Frontiers in pharmacology (12-06-2024)
    “…Cystic fibrosis transmembrane conductance regulator modulators are the only available treatment for cystic fibrosis. Although elexacaftor/tezacaftor/ivacaftor…”
    Get full text
    Journal Article
  2. 2

    Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes by Cillóniz, C., Ewig, S., Polverino, E., Muñoz-Almagro, C., Marco, F., Gabarrús, A., Menéndez, R., Mensa, J., Torres, A.

    Published in Clinical microbiology and infection (01-11-2012)
    “…The aim of this study was to evaluate the clinical characteristics, predictors and outcomes of pneumococcal pneumonia developing pulmonary complications and…”
    Get full text
    Journal Article
  3. 3

    Nursing home-acquired pneumonia: a 10 year single-centre experience by Polverino, E, Dambrava, P, Cillóniz, C, Balasso, V, Marcos, M A, Esquinas, C, Mensa, J, Ewig, S, Torres, A

    Published in Thorax (01-04-2010)
    “…Pneumonia among nursing home (NH) residents has increased considerably in recent years, but it remains unclear whether it should be considered as…”
    Get more information
    Journal Article
  4. 4

    Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients by LIAPIKOU, A, POLVERINO, E, EWIG, S, CILLONLZ, C, MARCOS, M. A, MENSA, J, BELLO, S, MARTIN-LOECHES, I, MENENDEZ, R, TORRES, A

    Published in The European respiratory journal (01-04-2012)
    “…Chronic obstructive pulmonary disease (COPD) is a frequent comorbidity in patients with community-acquired pneumonia (CAP). We investigated the impact of COPD…”
    Get full text
    Journal Article
  5. 5

    Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial by Herrero-Cortina, B, Vilaró, J, Martí, D, Torres, A, San Miguel-Pagola, M, Alcaraz, V, Polverino, E

    Published in Physiotherapy (01-12-2016)
    “…Abstract Objective To compare the efficacy of three slow expiratory airway clearance techniques (ACTs). Design Randomised crossover trial. Setting Tertiary…”
    Get full text
    Journal Article
  6. 6

    Acute exacerbations of COPD: risk factors for failure and relapse by Mantero, Marco, Rogliani, Paola, Di Pasquale, Marta, Polverino, Eva, Crisafulli, Ernesto, Guerrero, Monica, Gramegna, Andrea, Cazzola, Mario, Blasi, Francesco

    “…Acute exacerbations are a leading cause of worsening COPD in terms of lung function decline, quality of life, and survival. They also have a relevant economic…”
    Get full text
    Journal Article
  7. 7

    Community-acquired pneumonia by Polverino, E, Torres Marti, A

    Published in Minerva anestesiologica (01-02-2011)
    “…Despite the remarkable advances in antibiotic therapies, diagnostic tools, prevention campaigns and intensive care, community-acquired pneumonia (CAP) is still…”
    Get full text
    Journal Article
  8. 8

    Factors associated with inflammatory cytokine patterns in community-acquired pneumonia by MARTINEZ, R, MENENDEZ, R, REYES, S, POLVERINO, E, CILLONIZ, C, MARTINEZ, A, ESQUINAS, C, FILELLA, X, RAMIREZ, P, TORRES, A

    Published in The European respiratory journal (01-02-2011)
    “…Raised systemic levels of interleukin (IL)-6 and IL-10 cytokines have been associated with poorer outcome in community-acquired pneumonia. The aim of our study…”
    Get full text
    Journal Article
  9. 9

    Stability in community-acquired pneumonia: one step forward with markers? by Menéndez, R, Martinez, R, Reyes, S, Mensa, J, Polverino, E, Filella, X, Esquinas, C, Martinez, A, Ramirez, P, Torres, A

    Published in Thorax (01-11-2009)
    “…Biological markers as an expression of systemic inflammation have been recognised as useful for evaluating the host response in community-acquired pneumonia…”
    Get more information
    Journal Article
  10. 10

    Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic by RIQUELME, R, TORRES, A, CONTRERAS, C, GABARRUS, A, FASCE, R, RIOSECO, M. L, EWIG, S, CILLONIZ, C, RIQUELME, M, INZUNZA, C, POLVERINO, E, GOMEZ, Y, MARCOS, M. A

    Published in The European respiratory journal (01-07-2011)
    “…We compared clinical presentation, complications and outcome in patients with influenza A (H1N1) and seasonal influenza pneumonia. The group of patients with…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Microbial aetiology of community-acquired pneumonia and its relation to severity by Cillóniz, Catia, Ewig, Santiago, Polverino, Eva, Marcos, Maria Angeles, Esquinas, Cristina, Gabarrús, Albert, Mensa, Josep, Torres, Antoni

    Published in Thorax (01-04-2011)
    “…The distribution of the microbial aetiology and mortality of community-acquired pneumonia (CAP) was investigated in relation to the clinical setting and…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial by Herrero-Cortina, Beatriz, Alcaraz, Victoria, Vilaró, Jordi, Torres, Antoni, Polverino, Eva

    “…The role of hyaluronic acid plus hypertonic saline (HA+HS) as a mucoactive treatment in patients with bronchiectasis is still unknown. This study evaluated…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20